Thus, due to its fundamental role in promoting hepatic glucose production, therapeutic strategies aimed at both activating the GCGR to acutely rescue from hypoglycemia and at blocking glucagon-mediated hyperglycemia for the treatment of type 2 diabetes (T2D) have been pursued (8). The gene discussed is GCG; the disease is Hyperglycemia.